412 related articles for article (PubMed ID: 22461318)
1. SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutières syndrome-associated mutations.
Goncalves A; Karayel E; Rice GI; Bennett KL; Crow YJ; Superti-Furga G; Bürckstümmer T
Hum Mutat; 2012 Jul; 33(7):1116-22. PubMed ID: 22461318
[TBL] [Abstract][Full Text] [Related]
2. The eukaryotic elongation factor eEF1A1 interacts with SAMHD1.
Morrissey C; Schwefel D; Ennis-Adeniran V; Taylor IA; Crow YJ; Webb M
Biochem J; 2015 Feb; 466(1):69-76. PubMed ID: 25423367
[TBL] [Abstract][Full Text] [Related]
3. Single-stranded nucleic acids promote SAMHD1 complex formation.
Tüngler V; Staroske W; Kind B; Dobrick M; Kretschmer S; Schmidt F; Krug C; Lorenz M; Chara O; Schwille P; Lee-Kirsch MA
J Mol Med (Berl); 2013 Jun; 91(6):759-70. PubMed ID: 23371319
[TBL] [Abstract][Full Text] [Related]
4. Aicardi-Goutières syndrome and systemic lupus erythematosus (SLE) in a 12-year-old boy with SAMHD1 mutations.
Ramantani G; Häusler M; Niggemann P; Wessling B; Guttmann H; Mull M; Tenbrock K; Lee-Kirsch MA
J Child Neurol; 2011 Nov; 26(11):1425-8. PubMed ID: 21670392
[TBL] [Abstract][Full Text] [Related]
5. SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection.
Berger A; Sommer AF; Zwarg J; Hamdorf M; Welzel K; Esly N; Panitz S; Reuter A; Ramos I; Jatiani A; Mulder LC; Fernandez-Sesma A; Rutsch F; Simon V; König R; Flory E
PLoS Pathog; 2011 Dec; 7(12):e1002425. PubMed ID: 22174685
[TBL] [Abstract][Full Text] [Related]
6. A possible genotype-phenotype correlation in Ashkenazi-Jewish individuals with Aicardi-Goutières syndrome associated with SAMHD1 mutation.
Straussberg R; Marom D; Sanado-Inbar E; Lakovsky Y; Horev G; Shalev SA; Lev D; Lerman-Sagie T; Leshinsky-Silver E
J Child Neurol; 2015 Mar; 30(4):490-5. PubMed ID: 25246298
[TBL] [Abstract][Full Text] [Related]
7. With me or against me: Tumor suppressor and drug resistance activities of SAMHD1.
Herold N; Rudd SG; Sanjiv K; Kutzner J; Myrberg IH; Paulin CBJ; Olsen TK; Helleday T; Henter JI; Schaller T
Exp Hematol; 2017 Aug; 52():32-39. PubMed ID: 28502830
[TBL] [Abstract][Full Text] [Related]
8. Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome.
Ramantani G; Kohlhase J; Hertzberg C; Innes AM; Engel K; Hunger S; Borozdin W; Mah JK; Ungerath K; Walkenhorst H; Richardt HH; Buckard J; Bevot A; Siegel C; von Stülpnagel C; Ikonomidou C; Thomas K; Proud V; Niemann F; Wieczorek D; Häusler M; Niggemann P; Baltaci V; Conrad K; Lebon P; Lee-Kirsch MA
Arthritis Rheum; 2010 May; 62(5):1469-77. PubMed ID: 20131292
[TBL] [Abstract][Full Text] [Related]
9. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study.
Rice GI; Forte GM; Szynkiewicz M; Chase DS; Aeby A; Abdel-Hamid MS; Ackroyd S; Allcock R; Bailey KM; Balottin U; Barnerias C; Bernard G; Bodemer C; Botella MP; Cereda C; Chandler KE; Dabydeen L; Dale RC; De Laet C; De Goede CG; Del Toro M; Effat L; Enamorado NN; Fazzi E; Gener B; Haldre M; Lin JP; Livingston JH; Lourenco CM; Marques W; Oades P; Peterson P; Rasmussen M; Roubertie A; Schmidt JL; Shalev SA; Simon R; Spiegel R; Swoboda KJ; Temtamy SA; Vassallo G; Vilain CN; Vogt J; Wermenbol V; Whitehouse WP; Soler D; Olivieri I; Orcesi S; Aglan MS; Zaki MS; Abdel-Salam GM; Vanderver A; Kisand K; Rozenberg F; Lebon P; Crow YJ
Lancet Neurol; 2013 Dec; 12(12):1159-69. PubMed ID: 24183309
[TBL] [Abstract][Full Text] [Related]
10. A nationwide survey of Aicardi-Goutières syndrome patients identifies a strong association between dominant TREX1 mutations and chilblain lesions: Japanese cohort study.
Abe J; Nakamura K; Nishikomori R; Kato M; Mitsuiki N; Izawa K; Awaya T; Kawai T; Yasumi T; Toyoshima I; Hasegawa K; Ohshima Y; Hiragi T; Sasahara Y; Suzuki Y; Kikuchi M; Osaka H; Ohya T; Ninomiya S; Fujikawa S; Akasaka M; Iwata N; Kawakita A; Funatsuka M; Shintaku H; Ohara O; Ichinose H; Heike T
Rheumatology (Oxford); 2014 Mar; 53(3):448-58. PubMed ID: 24300241
[TBL] [Abstract][Full Text] [Related]
11. SAMHD1-deficient fibroblasts from Aicardi-Goutières Syndrome patients can escape senescence and accumulate mutations.
Franzolin E; Coletta S; Ferraro P; Pontarin G; D'Aronco G; Stevanoni M; Palumbo E; Cagnin S; Bertoldi L; Feltrin E; Valle G; Russo A; Bianchi V; Rampazzo C
FASEB J; 2020 Jan; 34(1):631-647. PubMed ID: 31914608
[TBL] [Abstract][Full Text] [Related]
12. SAMHD1 prevents autoimmunity by maintaining genome stability.
Kretschmer S; Wolf C; König N; Staroske W; Guck J; Häusler M; Luksch H; Nguyen LA; Kim B; Alexopoulou D; Dahl A; Rapp A; Cardoso MC; Shevchenko A; Lee-Kirsch MA
Ann Rheum Dis; 2015 Mar; 74(3):e17. PubMed ID: 24445253
[TBL] [Abstract][Full Text] [Related]
13. Characterization of samhd1 morphant zebrafish recapitulates features of the human type I interferonopathy Aicardi-Goutières syndrome.
Kasher PR; Jenkinson EM; Briolat V; Gent D; Morrissey C; Zeef LA; Rice GI; Levraud JP; Crow YJ
J Immunol; 2015 Mar; 194(6):2819-25. PubMed ID: 25672750
[TBL] [Abstract][Full Text] [Related]
14. The ribonuclease activity of SAMHD1 is required for HIV-1 restriction.
Ryoo J; Choi J; Oh C; Kim S; Seo M; Kim SY; Seo D; Kim J; White TE; Brandariz-Nuñez A; Diaz-Griffero F; Yun CH; Hollenbaugh JA; Kim B; Baek D; Ahn K
Nat Med; 2014 Aug; 20(8):936-41. PubMed ID: 25038827
[TBL] [Abstract][Full Text] [Related]
15. A SAMHD1 mutation associated with Aicardi-Goutières syndrome uncouples the ability of SAMHD1 to restrict HIV-1 from its ability to downmodulate type I interferon in humans.
White TE; Brandariz-Nuñez A; Martinez-Lopez A; Knowlton C; Lenzi G; Kim B; Ivanov D; Diaz-Griffero F
Hum Mutat; 2017 Jun; 38(6):658-668. PubMed ID: 28229507
[TBL] [Abstract][Full Text] [Related]
16. Cerebral vasculopathy is a common feature in Aicardi-Goutieres syndrome associated with SAMHD1 mutations.
du Moulin M; Nürnberg P; Crow YJ; Rutsch F
Proc Natl Acad Sci U S A; 2011 Jun; 108(26):E232; author reply E233. PubMed ID: 21633013
[No Abstract] [Full Text] [Related]
17. SAMHD1: a novel antiviral factor in intrinsic immunity.
Chen Z; Zhang L; Ying S
Future Microbiol; 2012 Sep; 7(9):1117-26. PubMed ID: 22953710
[TBL] [Abstract][Full Text] [Related]
18. SAMHD1 host restriction factor: a link with innate immune sensing of retrovirus infection.
Sze A; Olagnier D; Lin R; van Grevenynghe J; Hiscott J
J Mol Biol; 2013 Dec; 425(24):4981-94. PubMed ID: 24161438
[TBL] [Abstract][Full Text] [Related]
19. SAMHD1-dependent retroviral control and escape in mice.
Rehwinkel J; Maelfait J; Bridgeman A; Rigby R; Hayward B; Liberatore RA; Bieniasz PD; Towers GJ; Moita LF; Crow YJ; Bonthron DT; Reis e Sousa C
EMBO J; 2013 Sep; 32(18):2454-62. PubMed ID: 23872947
[TBL] [Abstract][Full Text] [Related]
20. Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond.
Livingston JH; Crow YJ
Neuropediatrics; 2016 Dec; 47(6):355-360. PubMed ID: 27643693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
